Crescendo Biologics Limited

Thomas Sandal

Brian Timothy McGuinness

Mike Romanos

Ulla Lashmar

Chris Rossant

Lorraine Thompson

Yumin Teng

Karen Bannister

Bryan Edwards

Nikki Royle

Isabelle Osuch

Daniel Pettit

Michele Writer

Eleanora Balloi

Normann Goodwin

Brian Mcguinness

The invention relates to stable and non-aggregating compositions comprising an IL-17A binding molecule, in particular a single domain antibody. Such compositions are useful for topical administration in the treatment of disease, for example skin disease or asthma.

Compositions for treatment of disorders

The invention relates to binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.

Therapeutic molecules

Binding molecules to IL-17A. The binding molecules are useful in the treatment of disorders, for example psoriasis.

IL-17A binding proteins

The disclosure relates to binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.

Molecules that bind prostate specific membrane antigen (PSMA)

Composition for treatment of disorders

Growing community of inventors

Cambridge, United Kingdom

Thomas Sandal